Stocks › EVH
Evolent Health, Inc.
EVH·NYSE·
United States·USD
United States·USD$3.84
+0.23 (+6.37%)
Close · Oct 6, 2026 · Close Prices from Tiingo.com
EVH
Evolent Health, Inc. · NYSE
Nasdaq 100S&P 500
Filings
Default90D1Y5YALL
EVHS&P 500 (rebased)
Congress BuyCongress SellInsider BuyInsider SellForm 1448-K ResultsLobbying
Loading price history…
Daily closes, adjusted for splits and dividends · Close Prices from Tiingo.comHover a marker, every one is a filing · move across the line for the crosshair
Congressional Trades
Recent trades of EVH by members of U.S. Congress · 7 on record
| Politician | Stock | Type | Filed | Traded | |
|---|---|---|---|---|---|
 Greg GianforteHouse · R · MT |
EVHEvolent Health, Inc. · Stock |
Sale $50,001 - $100,000 |
May 29, 2020 | May 11, 2020 | Filing ↗ |
| Greg GianforteHouse · R · MT |
EVHEvolent Health, Inc. · Stock |
Purchase $100,001 - $250,000 |
Nov 27, 2019 | Oct 11, 2019 | Filing ↗ |
| Greg GianforteHouse · R · MT |
EVHEvolent Health, Inc. · Stock |
Sale $50,001 - $100,000 |
Oct 20, 2019 | Sep 10, 2019 | Filing ↗ |
| Greg GianforteHouse · R · MT |
EVHEvolent Health, Inc. · Stock |
Purchase $15,001 - $50,000 |
Jan 23, 2019 | Dec 20, 2018 | Filing ↗ |
| Greg GianforteHouse · R · MT |
EVHEvolent Health, Inc. · Stock |
Purchase $50,001 - $100,000 |
Jun 15, 2018 | Jun 7, 2018 | Filing ↗ |
| Greg GianforteHouse · R · MT |
EVHEvolent Health, Inc. · Stock |
Purchase $15,001 - $50,000 |
Feb 8, 2018 | Jan 29, 2018 | Filing ↗ |
| Greg GianforteHouse · R · MT |
EVHEvolent Health, Inc. · Stock |
Sale $15,001 - $50,000 |
Jan 4, 2018 | Dec 29, 2017 | Filing ↗ |
Whale Activity
Position changes in EVH reported for 2026-06-30 by 16 tracked institutional filers
- Increased4
- New0
- Held2
- Decreased4
- Closed0
- No prior filing6
| Filer | Shares | Value | Change |
|---|---|---|---|
| BlackRock, Inc. | 14.8M | $80.3M | increased |
| PenderFund Capital Management Ltd. | 42.0M | $31.5M | — |
| D. E. Shaw & Co., Inc. | 5.1M | $27.7M | decreased |
| VANGUARD CAPITAL MANAGEMENT LLC | 4.8M | $26.0M | decreased |
| PenderFund Capital Management Ltd. | 23.4M | $19.0M | — |
| D. E. Shaw & Co., Inc. | 20.2M | $14.9M | held |
| SILVERBACK ASSET MANAGEMENT LLC | 13.5M | $10.6M | — |
| SILVERBACK ASSET MANAGEMENT LLC | 10.0M | $7.4M | — |
| VANGUARD PORTFOLIO MANAGEMENT LLC | 1.3M | $7.3M | increased |
| TWO SIGMA INVESTMENTS, LP | 1.3M | $6.8M | increased |
| BlackRock, Inc. | 7.6M | $5.6M | increased |
| CITADEL ADVISORS LLC | 488.8K | $2.6M | decreased |
KeyVex tracks a curated set of large 13F filers plus the largest positions in recent filings, so this is a sample of institutional activity, not the whole market.
Insider Trading
Net shares bought (+) or sold (−) on the open market by EVH insiders, by quarter · Form 4
Recent Insider Transactions
626 transactions on record · newest first
| Insider | Type | Shares | Price | Value | Date | |
|---|---|---|---|---|---|---|
| McCarthy Daniel JosephPRESIDENT | Sale | −65.9K | $5.00 | $329K | Aug 26, 2026 | Form 4 ↗ |
| Ajayi ToyinDirector | Grant / award | +41.1K | $0.00 | $0 | Jun 4, 2026 | Form 4 ↗ |
| Glass Russell MonroeDirector | Grant / award | +41.1K | $0.00 | $0 | Jun 4, 2026 | Form 4 ↗ |
| GRUA PETER JDirector | Grant / award | +41.1K | $0.00 | $0 | Jun 4, 2026 | Form 4 ↗ |
| GUERTIN SHAWN MDirector | Grant / award | +41.1K | $0.00 | $0 | Jun 4, 2026 | Form 4 ↗ |
| Jelinek Richard MDirector | Grant / award | +41.1K | $0.00 | $0 | Jun 4, 2026 | Form 4 ↗ |
| KECK KIMDirector | Grant / award | +41.1K | $0.00 | $0 | Jun 4, 2026 | Form 4 ↗ |
| Smith Jill D.Director | Grant / award | +41.1K | $0.00 | $0 | Jun 4, 2026 | Form 4 ↗ |
| Springstubb Brendan BDirector | Grant / award | +41.1K | $0.00 | $0 | Jun 4, 2026 | Form 4 ↗ |
| Barbarosh Craig A.Director | Grant / award | +41.1K | $0.00 | $0 | Jun 4, 2026 | Form 4 ↗ |
| Weinberg JonathanGeneral Counsel | Tax withholding | −8,275 | $3.51 | $29K | Mar 3, 2026 | Form 4 ↗ |
| Blackley SethChief Executive Officer · Director | Tax withholding | −24.1K | $3.51 | $84K | Mar 3, 2026 | Form 4 ↗ |
| McCarthy Daniel JosephPRESIDENT | Tax withholding | −24.0K | $3.51 | $84K | Mar 3, 2026 | Form 4 ↗ |
| Shams AammaadChief Accounting Officer | Tax withholding | −4,311 | $3.51 | $15K | Mar 3, 2026 | Form 4 ↗ |
| Weinberg JonathanGeneral Counsel | Tax withholding | −1,896 | $3.58 | $7K | Mar 2, 2026 | Form 4 ↗ |
| Weinberg JonathanGeneral Counsel | Grant / award | +4,910 | $0.00 | $0 | Mar 2, 2026 | Form 4 ↗ |
| Blackley SethChief Executive Officer · Director | Tax withholding | −17.7K | $3.58 | $63K | Mar 2, 2026 | Form 4 ↗ |
| Blackley SethChief Executive Officer · Director | Grant / award | +58.9K | $0.00 | $0 | Mar 2, 2026 | Form 4 ↗ |
| McCarthy Daniel JosephPRESIDENT | Tax withholding | −18.2K | $3.58 | $65K | Mar 2, 2026 | Form 4 ↗ |
| McCarthy Daniel JosephPRESIDENT | Grant / award | +39.3K | $0.00 | $0 | Mar 2, 2026 | Form 4 ↗ |
Fund Holders
Mutual funds and ETFs holding EVH · SEC Form N-PORT
| Fund | Shares | Value | % of fund | As of |
|---|---|---|---|---|
| VANGUARD TOTAL STOCK MARKET INDEX FUND VANGUARD INDEX FUNDS | 3.4M | $18.3M | 0.00% | Jun 30, 2026 |
| iShares Russell 2000 ETF iShares Trust | 3.0M | $16.0M | 0.02% | Jun 30, 2026 |
| VANGUARD EXTENDED MARKET INDEX FUND VANGUARD INDEX FUNDS | 1.3M | $7.0M | 0.01% | Jun 30, 2026 |
| Eventide Healthcare & Life Sciences Fund MUTUAL FUND SERIES TRUST | 2.5M | $5.8M | 0.37% | Mar 31, 2026 |
| Nuveen Quant Small Cap Equity Fund TIAA-CREF Funds | 1.4M | $4.4M | 0.11% | Jul 31, 2026 |
| Fidelity Small Cap Index Fund Fidelity Salem Street Trust | 1.3M | $3.9M | 0.01% | Jul 31, 2026 |
| iShares Russell 2000 Value ETF iShares Trust | 688.0K | $3.7M | 0.03% | Jun 30, 2026 |
| BlackRock Advantage Small Cap Core Fund BlackRock Funds | 793.0K | $3.1M | 0.06% | May 29, 2026 |
| College Retirement Equities Fund - Total Global Stock Account College Retirement Equities Fund | 574.0K | $3.1M | 0.00% | Jun 30, 2026 |
| Schwab Fundamental U.S. Small Company ETF SCHWAB STRATEGIC TRUST | 721.6K | $2.9M | 0.03% | May 31, 2026 |
Mutual funds and ETFs whose N-PORT filings list EVH's shares (CUSIP 30050B101), each fund at its latest report since Mar 7, 2026, largest positions first. Bonds, options and short positions are left out.
Activist & Passive Stakes
Schedule 13D / 13G beneficial-ownership filings
Corporate Lobbying
Estimated quarterly lobbying spending reported under the LDA, filings naming Evolent Health, Inc. as client
No lobbying filings found naming Evolent Health, Inc. as the client.
Government Contracts
Federal awards to Evolent Health, Inc. · USAspending
No federal contract awards found for Evolent Health, Inc..
U.S. Patents
Recent USPTO applications naming Evolent Health, Inc.
No USPTO patent applications found for Evolent Health, Inc..
Annual Financials
From EVH's 10-K filings · XBRL
No annual XBRL figures on record for EVH. KeyVex's fundamentals cover about 130 large companies so far.
Stock Splits
Every split and reverse split in the price history
No stock splits in EVH's price history.
About Evolent Health, Inc.
From SEC EDGAR company records
Industry (SIC 8741)Services-Management Services
SectorIndustrials
HeadquartersARLINGTON, VA
IncorporatedDE
SEC CIK0001628908 ↗